- Home
- HCWB vs MGIH Comparison
HCWB vs MGIH Comparison
Compare HCWB & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- MGIH
- Stock Information
- Founded
- HCWB 2018
- MGIH 1978
- Country
- HCWB United States
- MGIH Hong Kong
- Employees
- HCWB N/A
- MGIH N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- MGIH Publishing
- Sector
- HCWB Health Care
- MGIH Consumer Discretionary
- Exchange
- HCWB Nasdaq
- MGIH Nasdaq
- Market Cap
- HCWB 16.1M
- MGIH 17.3M
- IPO Year
- HCWB 2021
- MGIH 2023
- Fundamental
- Price
- HCWB $4.44
- MGIH $1.59
- Analyst Decision
- HCWB Strong Buy
- MGIH
- Analyst Count
- HCWB 1
- MGIH 0
- Target Price
- HCWB $35.00
- MGIH N/A
- AVG Volume (30 Days)
- HCWB 236.1K
- MGIH 12.1K
- Earning Date
- HCWB 08-13-2025
- MGIH 07-07-2025
- Dividend Yield
- HCWB N/A
- MGIH N/A
- EPS Growth
- HCWB N/A
- MGIH N/A
- EPS
- HCWB N/A
- MGIH N/A
- Revenue
- HCWB $1,445,145.00
- MGIH $28,866,993.00
- Revenue This Year
- HCWB N/A
- MGIH N/A
- Revenue Next Year
- HCWB N/A
- MGIH N/A
- P/E Ratio
- HCWB N/A
- MGIH N/A
- Revenue Growth
- HCWB N/A
- MGIH N/A
- 52 Week Low
- HCWB $3.55
- MGIH $1.32
- 52 Week High
- HCWB $100.80
- MGIH $6.83
- Technical
- Relative Strength Index (RSI)
- HCWB 28.61
- MGIH 49.50
- Support Level
- HCWB $4.05
- MGIH $1.52
- Resistance Level
- HCWB $5.77
- MGIH $1.71
- Average True Range (ATR)
- HCWB 0.49
- MGIH 0.09
- MACD
- HCWB -0.07
- MGIH -0.00
- Stochastic Oscillator
- HCWB 9.98
- MGIH 36.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About MGIH Millennium Group International Holdings Limited
Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.